RhGM-CSF

sargramostim (recombinant human granulocyte-macrophage colony-stimulating factor)

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for RhGM-CSF, covering 2016-01-20 to 2023-06-13. Get the full timeline:

Most recent: Clinical Trial Update: Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer [Phase 2]